Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert K. Zeldin currently holds 100,000 shares of ACCELERON PHARMA INC (XLRN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert K. Zeldin has been a net buyer of XLRN stock. They have purchased $39.5K and sold $0 worth of shares.
Robert K. Zeldin's most recent insider trade was on Jun 25, 2026, when they sold 100,000 shares at $0.00 per share.
Robert K. Zeldin serves as Executive at ACCELERON PHARMA INC (XLRN). They have executed 25 insider transactions totaling $39.5K over their tenure at the company.
Robert K. Zeldin holds the position of Executive at ACCELERON PHARMA INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Robert K. Zeldin has shown a buying trading pattern, with $39.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert K. Zeldin was on Jan 14, 2023, when they sold $206.3K worth of MGTX shares. This transaction involved 29,513 shares at $6.99 per share.
Robert K. Zeldin currently owns 100,000 shares of ACCELERON PHARMA INC (XLRN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert K. Zeldin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert K. Zeldin has 25 Form 4 filings on record as an insider at ACCELERON PHARMA INC.
Set alerts for Robert K. Zeldin and 40,000+ other insiders.